Literature DB >> 31571082

Changes in the Regulatory T-Lymphocyte Counts in HIV-Infected Patients with a Discordant Response to Antiretroviral Therapy.

E V Saidakova1, K V Shmagel2, N G Shmagel2, L B Korolevskaya2, V A Chereshnev2,3.   

Abstract

We examined HIV-infected patients with different efficacies of immune system restoration during antiretroviral therapy. The study showed that against the background of low CD4+ T cell counts, subjects with a discordant immunologic response (patients with <350 CD4+ T cells per μL of blood after more than two years of treatment) develop a regulatory CD4+ T cell (Treg) deficiency. Furthermore, in these patients, the immunodeficiency is accompanied by an increase in the Treg frequency. Accumulation of regulatory T lymphocytes in the blood of HIV‑infected subjects with discordant response to the treatment indicates a high viability of this T cell subset.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31571082     DOI: 10.1134/S0012496619040082

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


  12 in total

1.  Depletion of regulatory T cells in HIV infection is associated with immune activation.

Authors:  Mark P Eggena; Banson Barugahare; Norman Jones; Martin Okello; Steven Mutalya; Cissy Kityo; Peter Mugyenyi; Huyen Cao
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

Review 2.  Immunological recovery and antiretroviral therapy in HIV-1 infection.

Authors:  Manuel Battegay; Reto Nüesch; Bernard Hirschel; Gilbert R Kaufmann
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

3.  Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.

Authors:  Giulia Marchetti; Andrea Gori; Anna Casabianca; Mauro Magnani; Fabio Franzetti; Mario Clerici; Carlo-Federico Perno; Antonella d'Arminio Monforte; Massimo Galli; Luca Meroni
Journal:  AIDS       Date:  2006-08-22       Impact factor: 4.177

4.  Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

Authors:  Stefania Piconi; Daria Trabattoni; Andrea Gori; Serena Parisotto; Carlo Magni; Paola Meraviglia; Alessandra Bandera; Amedeo Capetti; Giuliano Rizzardini; Mario Clerici
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

5.  Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.

Authors:  Giuseppe Lapadula; Alessandro Cozzi-Lepri; Giulia Marchetti; Andrea Antinori; Alessandro Chiodera; Emanuele Nicastri; Giustino Parruti; Massimo Galli; Andrea Gori; Antonella d'Arminio Monforte
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

6.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Authors:  Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

7.  Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain.

Authors:  Maria E Moreno-Fernandez; Wildeman Zapata; Jason T Blackard; Genoveffa Franchini; Claire A Chougnet
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

8.  Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy.

Authors:  Pietro Presicce; Kris Orsborn; Eileen King; Jesse Pratt; Carl J Fichtenbaum; Claire A Chougnet
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

9.  Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy.

Authors:  Claudia Nobrega; Ana Horta; Vítor Coutinho-Teixeira; Ana Martins-Ribeiro; Ana Baldaia; Rita Rb-Silva; Catarina L Santos; Rui Sarmento-Castro; Margarida Correia-Neves
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.